BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25683871)

  • 1. C-terminal cleavage of human Foxp3 at a proprotein convertase motif abrogates its suppressive function.
    Elhage R; Cheraï M; Levacher B; Darrasse-Jeze G; Baillou C; Zhao X; Khatib AM; Piaggio E; Klatzmann D
    Scand J Immunol; 2015 Apr; 81(4):229-39. PubMed ID: 25683871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foxp3 processing by proprotein convertases and control of regulatory T cell function.
    de Zoeten EF; Lee I; Wang L; Chen C; Ge G; Wells AD; Hancock WW; Ozkaynak E
    J Biol Chem; 2009 Feb; 284(9):5709-16. PubMed ID: 19117830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-Expression of FOXP3FL and FOXP3Δ2 Isoforms Is Required for Optimal Treg-Like Cell Phenotypes and Suppressive Function.
    Sato Y; Liu J; Lee E; Perriman R; Roncarolo MG; Bacchetta R
    Front Immunol; 2021; 12():752394. PubMed ID: 34737751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
    Huang H; Dawicki W; Zhang X; Town J; Gordon JR
    J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune dysregulation in chronic stress: a quantitative and functional assessment of regulatory T cells.
    Kim HR; Moon S; Lee HK; Kang JL; Oh S; Seoh JY
    Neuroimmunomodulation; 2012; 19(3):187-94. PubMed ID: 22262136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells.
    Kaur G; Goodall JC; Jarvis LB; Hill Gaston JS
    Mol Immunol; 2010; 48(1-3):321-32. PubMed ID: 20688398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
    Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
    Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome.
    Chi LJ; Wang HB; Zhang Y; Wang WZ
    J Neuroimmunol; 2007 Dec; 192(1-2):206-14. PubMed ID: 17997492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ FOXP3+ Regulatory T Cells Exhibit Impaired Ability to Suppress Effector T Cell Proliferation in Patients with Turner Syndrome.
    Lee YA; Kim HR; Lee JS; Jung HW; Kim HY; Lee GM; Lee J; Sim JH; Oh SJ; Chung DH; Shin CH; Yang SW
    PLoS One; 2015; 10(12):e0144549. PubMed ID: 26709833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXP3+ CD4+ Tregs lose suppressive potential but remain anergic during transient inflammation in human.
    Schadenberg AW; Vastert SJ; Evens FC; Kuis W; van Vught AJ; Jansen NJ; Prakken BJ
    Eur J Immunol; 2011 Apr; 41(4):1132-42. PubMed ID: 21381018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs.
    Mayer CT; Huntenburg J; Nandan A; Schmitt E; Czeloth N; Sparwasser T
    J Autoimmun; 2013 Dec; 47():73-82. PubMed ID: 24055067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxp3 regulates human natural CD4+CD25+ regulatory T-cell-mediated suppression of xenogeneic response.
    Sun L; Yi S; O'Connell PJ
    Xenotransplantation; 2010; 17(2):121-30. PubMed ID: 20522244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxp3 lacking exons 2 and 7 is unable to confer suppressive ability to regulatory T cells in vivo.
    Joly AL; Liu S; Dahlberg CI; Mailer RK; Westerberg LS; Andersson J
    J Autoimmun; 2015 Sep; 63():23-30. PubMed ID: 26149776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226.
    Fuhrman CA; Yeh WI; Seay HR; Saikumar Lakshmi P; Chopra G; Zhang L; Perry DJ; McClymont SA; Yadav M; Lopez MC; Baker HV; Zhang Y; Li Y; Whitley M; von Schack D; Atkinson MA; Bluestone JA; Brusko TM
    J Immunol; 2015 Jul; 195(1):145-55. PubMed ID: 25994968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effector T cell response to ryegrass pollen is counterregulated by simultaneous induction of regulatory T cells.
    Mittag D; Scholzen A; Varese N; Baxter L; Paukovics G; Harrison LC; Rolland JM; O'Hehir RE
    J Immunol; 2010 May; 184(9):4708-16. PubMed ID: 20308632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTD-hFOXP3 protein acts as an immune regulator to convert human CD4(+)CD25(-) T cells to regulatory T-like cells.
    Liu X; Xu X; Lin X; Tian Y; Ji B; Xia S; Xu S; Yin Q; Zhang M; Jiao Z; Wang S; Xu H; Shao Q
    J Cell Biochem; 2012 Dec; 113(12):3797-809. PubMed ID: 22806628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
    Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
    Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.